Digestive Disease Research Institute

Digestive Disease Research Institute (DDRI) is a specialized clinical research organization and site focused on the advancement of gastroenterology and hepatology therapeutics. Located in Southern California, the institute conducts Phase II through IV clinical trials in collaboration with global pharmaceutical and biotechnology sponsors. DDRI's research expertise spans a wide range of conditions, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and metabolic dysfunction-associated steatohepatitis (MASH). The institute provides comprehensive clinical trial management services, offering patients access to emerging therapies while delivering high-quality data to support regulatory submissions. By bridging the gap between laboratory research and clinical practice, DDRI plays a significant role in the development of next-generation digestive health treatments.